Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
128. Use of chimeric adenoviral vectors to assess capsid neutralization determinants
Ist Teil von
Molecular therapy, 2004-05, Vol.9 (S1), p.S50-S50
Ort / Verlag
Milwaukee: Elsevier Limited
Erscheinungsjahr
2004
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
Use of adenoviral gene therapy vectors based on different non-cross reacting serotypes is being investigated by several groups as a means to administer adenoviral vectors, either in a re-administration setting, or in subjects with circulating antibodies against the common serotypes such as Ad2 or Ad5. We have previously developed GFP expressing vectors using the chimpanzee adenoviruses Pan 6 (C6-GFP) and Pan 7 (C7-GFP). We have determined that administration of either one of the two chimpanzee adenovirus vectors does not affect the transduction efficiency of the other vector while re-administration of the same vector is severely compromised. Adenoviruses have three major capsid proteins, hexon, penton base, and fiber, which elicit the production of circulating antibodies. We wished to elucidate the relative importance of each of the three capsid components in preventing transduction in a gene therapy setting. In order to do this we have generated a panel of GFP expressing vectors that are chimeric between Pan 6 and Pan 7 where the hexon protein or the fiber protein or both hexon and fiber proteins of the Pan 7 vector have been replaced by those from Pan 6. Balb/C mice were immunized with either Pan 6 or Pan 7 and re-administration (by tail vein injection) was attempted 3 weeks later using each of the five GFP expressing vectors (C6-GFP, C7-GFP, and the three chimeric vectors). Three days later the level of liver transduction was estimated qualitatively by examining liver sections for the presence of GFP expression and quantitatively by estimating copies of GFP DNA by Taqman analysis. The data showed that antibodies to both hexon and fiber are important in preventing re-administration of adenoviral vectors.